stella
beta
Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder — Stella
Recruiting
Back to Neuromyelitis Optica Spectrum Disorders (NMOSD) trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
Tianjin Medical University General Hospital, Department of Neurology, Tianjin
View full record on ClinicalTrials.gov